Intervention not reported
Type 2 diabetes · healthy normal weighted participants recruited through leaflets from Italy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Cardiovascular mortality (11.1 to 26 y) · health professionals from the USA and participants (“healthy volunteers from the Biobank cohort”) from the UK
The intervention showed no clear difference in cardiovascular mortality (11.1 to 26 y) (low certainty).
1 finding from 1 review
HR 1 [0.95, 1.06]
203063 participants
Low
Intervention not reported
All‐cause mortality (11.1 y) · health professionals from the USA and participants (“healthy volunteers from the Biobank cohort”) from the UK
It is very uncertain whether the intervention changes all‐cause mortality (11.1 y) (very low certainty).
1 finding from 1 review
HR 1 [0.99, 1.01]
159265 participants
Very low
Intervention not reported
Non‐fatal MI (26 y) · health professionals from the USA and participants (“healthy volunteers from the Biobank cohort”) from the UK
The intervention showed no clear difference in non‐fatal MI (26 y) (low certainty).
1 finding from 1 review
HR 0.99 [0.89, 1.1]
43798 participants
Low
Intervention not reported
Stroke · health professionals from the USA and participants (“healthy volunteers from the Biobank cohort”) from the UK
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Peripheral artery disease · health professionals from the USA and participants (“healthy volunteers from the Biobank cohort”) from the UK
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Systolic blood pressure · health professionals from the USA and participants (“healthy volunteers from the Biobank cohort”) from the UK
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Type 2 diabetes (28 y) · health professionals from the USA and participants (“healthy volunteers from the Biobank cohort”) from the UK
The intervention may leads to higher type 2 diabetes (28 y) (low certainty).
1 finding from 1 review
HR 1.14 [1.07, 1.22]
71766 participants
Low
Intervention not reported
Cardiovascular mortality · healthy normal weighted participants recruited through leaflets from Italy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
All‐cause mortality · people with AHF
It is very uncertain whether ultrafiltration (UF) changes all‐cause mortality compared with usual care (UC) (very low certainty).
1 finding from 1 review
Patient readmissions · people with AHF
Ultrafiltration (UF) showed no clear difference in all‐cause rehospitalisation compared with usual care (UC) (low certainty).
1 finding from 1 review
Heart failure‐related rehospitalisation · people with AHF
Ultrafiltration (UF) showed no clear difference in heart failure‐related rehospitalisation compared with usual care (UC) (low certainty).
1 finding from 1 review
Need for mechanical invasive ventilation – up to and including 30 days · people with AHF
1 finding from 1 review
% Change in serum creatinine – at 30 days from discharge · people with AHF
1 finding from 1 review
New initiation of renal replacement therapy – at longest available · people with AHF
Ultrafiltration (UF) showed no clear difference in new initiation of renal replacement therapy – at longest available compared with usual care (UC) (low certainty).
1 finding from 1 review
Complications of central line insertion – in hospital · people with AHF
It is very uncertain whether ultrafiltration (UF) changes complications of central line insertion – in hospital compared with usual care (UC) (very low certainty).
1 finding from 1 review
All‐cause mortality · patients with coronary heart disease
Exercise‐based cardiac rehabilitation showed no clear difference in all‐cause mortality compared with 'no exercise' control (moderate certainty).
1 finding from 1 review
Cardiovascular mortality · patients with coronary heart disease
Exercise‐based cardiac rehabilitation showed no clear difference in cardiovascular mortality compared with 'no exercise' control (moderate certainty).
1 finding from 1 review
Fatal or nonfatal myocardial infarction · patients with coronary heart disease
Exercise‐based cardiac rehabilitation leads to lower fatal and/or non‐fatal MI compared with 'no exercise' control (high certainty).
1 finding from 1 review
Revascularisation ‐ CABG · patients with coronary heart disease
Exercise‐based cardiac rehabilitation showed no clear difference in revascularisation ‐ CABG compared with 'no exercise' control (high certainty).
1 finding from 1 review